by Stephan Lust | Feb 24, 2023 | Global Drug Facility, Stop TB Partnership
24 February 2023, Geneva, Switzerland – On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for: ITB-IDA/GDF-MED/2023/1, pretomanid...
by Stephan Lust | Apr 11, 2022 | Global Drug Facility, Stop TB Partnership
UPDATE 26 April 2022 – Reminder Please be informed that for the ITB-IDA/GDF – MED/2022/1, the deadline for submission/modification of product/s in FPP In-Market and/or country registration in FPP registration modules, including uploading of...
by Stephan Lust | Mar 24, 2022 | Global Drug Facility, IDA Team, Stop TB Partnership
Amsterdam, 24 March 2022 – Tuberculosis (TB) is one of the world’s most common and life threatening diseases, with over 95% of TB deaths occurring in low-and middle-income countries (LMICs). In 2019, an estimated 10 million people were diagnosed with TB worldwide...
by Stephan Lust | May 17, 2021 | Global Drug Facility, Stop TB Partnership
17 May 2021 – Geneva, Switzerland – On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for: ITB-IDA/GDF-FLD/2021/001, for...
by Stephan Lust | Sep 23, 2020 | Global Drug Facility, News, Stop TB Partnership
22 September 2020 – Geneva, Switzerland – On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for: ITB-IDA/GDF-FLD/2020/001,...
by Stephan Lust | Jul 7, 2020 | Global Drug Facility, Global Fund, Johnson & Johnson, News, Stop TB Partnership, USAID
On Monday July 6, Johnson & Johnson announced a price reduction of the anti-tuberculosis medicine bedaquiline, for low- and middle-income countries. Thanks to the support of USAID and the Global Fund, this price reduction could be achieved. The price dropped...
